Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS · Delayed Price · Currency is USD
0.2720
+0.0031 (1.14%)
May 30, 2025, 3:56 PM EDT

Northwest Biotherapeutics Revenue

Northwest Biotherapeutics had revenue of $375.00K in the quarter ending March 31, 2025, with 32.04% growth. This brings the company's revenue in the last twelve months to $1.47M, up 10.25% year-over-year. In the year 2024, Northwest Biotherapeutics had annual revenue of $1.38M, down -28.47%.

Revenue (ttm)
1.47M
Revenue Growth
+10.25%
P/S Ratio
267.73
Revenue / Employee
58.92K
Employees
25
Market Cap
394.36M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241.38M-550.00K-28.47%
Dec 31, 20231.93M249.00K14.80%
Dec 31, 20221.68M678.00K67.46%
Dec 31, 20211.01M-286.00K-22.15%
Dec 31, 20201.29M-1.12M-46.43%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition